Antleron

Ambachtenlaan 1
3001 Leuven
BE
Antleron
Foundation date
21/11/2014
Sector
#Biotechnology / R&D ServicesTherapeutic areas
- #Cardiovascular
- #Digestive system
- #Diseases of the blood and blood-forming organs - immune disorders
- #Injury - poisoning and certain other consequences of external causes
- #Musculoskeletal system and connective tissue
- #Skin and subcutaneous tissue
- #Symptoms - signs and abnormal clinical and laboratory findings - not elsewhere classified
We are Antleron, a nimble team that will revolutionise medicine by leading the development of next generation advanced therapies and medical devices. By merging the potential of cells, biomaterials, biologics, 3D printing and bioreactors we will accelerate the engineering of medicinal products, devices and processes that will change health care and result in a better life for all. The Antleron business philosophy is to create sustainable ventures through risk & reward sharing partnerships.
Upcoming events
All events-
0106 '23
KNOWLEDGE FOR GROWTH 2023
Event by: flanders.bio -
0506 '23
BIO International Convention 2023
Event by: Biotechnology Innovation Organisation -
0604 '23
Innovation for Health 2023
Event by: Hyphen Projects
Latest news
More news-
Celyad Oncology appoints Georges Rawadi as its new CEO
Tuesday March 28th 2023
Read more
-
BioLizard appoints Paul Vauterin as Chief Technology Officer
Monday March 27th 2023
Read more
-
ImmuneWatch receives Antwerp Innovation grant to accelerate vaccine development with AI
Monday March 27th 2023
Read more
Jobs
More jobs-
-
28/03/23
East Flanders
Postdoc researcher: Unravelling proteostasis machineries in jasmonate signalling in tomato
Permanent
VIB -
28/03/23
East Flanders
PhD student: Phosphoregulation in jasmonate-mediated plant stress responses
Permanent
VIB